Stable replication of the EBNA1/OriP-mediated baculovirus vector and its application to anti-HCV gene therapy
<p>Abstract</p> <p>Background</p> <p>Hepatitis C virus (HCV) is one of the main causes of liver-related morbidity and mortality. Although combined interferon-α-ribavirin therapy is effective for about 50% of the patients with HCV, better therapies are needed and prevent...
Main Authors: | Chang Myint OO, Suzuki Tomoyuki, Matsumoto Norihiko, Suzuki Hitoshi, Takaku Hiroshi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-10-01
|
Series: | Virology Journal |
Online Access: | http://www.virologyj.com/content/6/1/156 |
Similar Items
-
Retrofitting BACs with G418 resistance, luciferase, and <it>oriP </it>and <it>EBNA-1 </it>– new vectors for <it>in vitro </it>and <it>in vivo </it>delivery
by: Wagner Ernst, et al.
Published: (2003-02-01) -
Recombinant baculovirus expressing the FrC-OVA protein induces protective antitumor immunity in an EG7-OVA mouse model
by: Keigo Kondou, et al.
Published: (2019-10-01) -
Epstein-Barr Nuclear Antigen 1 modulates replication of <it>oriP</it>-plasmids by impeding replication and transcription fork migration through the family of repeats
by: Singh Gyanendra, et al.
Published: (2009-03-01) -
Sequences adjacent to oriP improve the persistence of Epstein-Barr virus-based episomes in B cells.
by: White, R, et al.
Published: (2001) -
Minicircle-oriP-IFNγ: a novel targeted gene therapeutic system for EBV positive human nasopharyngeal carcinoma.
by: Yufang Zuo, et al.
Published: (2011-05-01)